PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Phenotype | C0020541|portal hypertension |
| Sentences | 56 |
| PubMedID- 21424236 | portal hypertension in the setting of decompensated liver disease is managed medically (via endoscopy) or radiologically (via transjugular intrahepatic portosystemic shunt) with the aim to offer liver transplant as a permanent solution. |
| PubMedID- 24616589 | Bh4 concentration in liver tissue has little relation to the severity of portal hypertension in patients with chronic liver disease. |
| PubMedID- 24142390 | The insertion of a transjugular intrahepatic portosystemic shunt (tips) is a minimally invasive procedure used to relieve the signs and symptoms of portal hypertension in patients with liver disease. |
| PubMedID- 22610002 | Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease. |
| PubMedID- 25844525 | Analysis of peritoneal fluid was consistent with portal hypertension due to liver disease. |
| PubMedID- 22270437 | Background: cirrhotic liver disease commonly is complicated by portal hypertension, and the resultant porto-systemic shunts are an important cause of morbidity and mortality in cirrhotic patients. |
| PubMedID- 24796378 | Aim: liver fibrosis occurs as a result of several chronic liver diseases and leads to portal hypertension, cirrhosis and liver failure, often requiring liver transplantation. |
| PubMedID- 24613858 | Purpose of review: cirrhosis is the result of the progression of necroinflammatory liver diseases leading to fibrosis, portal hypertension, and a catabolic state, which might cause muscle wasting or sarcopenia. |
| PubMedID- 25568485 | However, ultrasound examination of the abdomen revealed parenchymal liver disease with portal hypertension and ascites. |
| PubMedID- 21813019 | To our knowledge, ha is the only serum marker that has been confirmed as an independent predictor of portal hypertension in patients with liver disease [20]. |
| PubMedID- 24457056 | Aitp has been classified either as a primary autoimmune disorder or as secondary to a number of underlying conditions such as lymphoproliferative disorders, myelodysplasia, autoimmune collagen vascular diseases (e.g., systemic lupus erythematosus, antiphospholipid antibody syndrome) liver disease with portal hypertension, drugs or viral infection. |
| PubMedID- 25147571 | The most common cause of colonic varices is portal hypertension associated with liver disease or secondary to pancreatic conditions, like chronic pancreatitis or malignancies. |
| PubMedID- 21978390 | Markers of impaired intestinal permeability are elevated in portal hypertension, particularly with severe liver disease, and in viral and alcoholic cirrhosis [11,32]. |
| PubMedID- 26117383 | Severe mdr3 deficiency typically presents during the first year of life or early childhood, often progressing to chronic liver disease with cirrhosis and portal hypertension, requiring liver transplantation. |
| PubMedID- 25667596 | Cirrhosis is scarring of the liver and also is the final stage of many chronic liver diseases, leading to portal hypertension and end-stage liver disease [1]. |
| PubMedID- 22623827 | He was a known case of alcoholic liver disease with portal hypertension categorised as child's class a. there was no visible caput medusae or audible periumbilical venous hum. |
| PubMedID- 22059111 | In most cases, no evidence of liver dysfunction is observed, and portal hypertension due to sarcoid liver diseases is a rareoccurrence. |
| PubMedID- 23671546 | Exclusionary criteria were contraindications to wbv [43], severe cf (forced expiratory volume in 1 minute (fev1 < 40% predicted)), inability to stand unaided for 30 minutes, long bone or vertebral fracture in the past six months, past/present history of osteoarthritis, presence of cf-liver disease with portal hypertension, neuropathy or myopathy and/or vitamin d deficiency (25-hydroxyvitamin d < 39 nmol/l) in the past three months. |
| PubMedID- 24820314 | Hps is a significant complication of portal hypertension in children with chronic liver disease and is an established indication for lt. |
| PubMedID- 24171010 | The authors concluded that patients who carry the z allele are at greater risk (or, ≈ 5) of developing severe liver disease with portal hypertension (31). |
| PubMedID- 25899245 | A diagnosis was made if they had features of chronic liver disease with evidence of portal hypertension, ascites, encephalopathy or liver and spleen imaging consistent with cirrhosis. |
| PubMedID- 25420739 | Variceal formation results from portal hypertension due to chronic liver disease. |
| PubMedID- 22986694 | Purpose: cystic-fibrosis-associated liver disease (cfld) may lead to portal hypertension (pht) and cirrhosis. |
| PubMedID- 20113491 | This fact is, nonetheless, expected since fatty liver disease does not lead to portal hypertension and, consequently, to the widening of the portal vein. |
| PubMedID- 21932390 | Targeting angiogenesis in chronic liver diseases with portal hypertension: anti-placenta growth factor inhibitor or multikinase inhibitor sorafenib. |
| PubMedID- 24714325 | As the patient has chronic liver disease along with portal hypertension, he has been referred for work up for liver transplantation. |
| PubMedID- 25661250 | This fibrotic response causes all the complications of end-stage liver disease, including portal hypertension, impaired metabolic capacity, synthetic dysfunction and ascites 1. unfortunately, currently no standard treatment for liver fibrosis is available and no appropriate antifibrotic drugs has emerged to be effective in human 6–8. |
| PubMedID- 22973991 | Objectives: transient elastography (te), as a non-invasive method, has been studied for evaluation of portal hypertension in patients with chronic liver diseases (cld) with variable results. |
| PubMedID- PMC3239438 | The patient was suffering from advanced liver disease with portal hypertension and multiple current inter abdominal abscesses. |
| PubMedID- 24771990 | Chronic liver disease, especially with associated portal hypertension, has also been linked to the presence of gi angioectasias and, as reported by some authors, they could be reversed after transjugular intrahepatic portosystemic shunt [34, 38, 39]. |
| PubMedID- 20065573 | Background/aim: esophageal varices (evs) are a serious consequence of portal hypertension in patients with liver diseases. |
| PubMedID- 23812037 | Therefore, hscs can contribute to portal hypertension in patients with chronic liver disease (cld). |
| PubMedID- 21712949 | Further evaluation showed that he had chronic liver disease with portal hypertension and was hepatitis b surface antigen-positive, indicating hepatitis b infection. |
| PubMedID- 25590846 | Furthermore, to exclude the effect of cardiovascular factors, patients with confirmed cardiovascular diseases or taking any agents affecting qtc interval before the establishment of achblf were excluded, such as β-blockers, even if it is recommended in patients with portal hypertension associated with chronic liver diseases. |
| PubMedID- 26201624 | Hepatic hydrothorax (hh) is an infrequent but a well-known complication of portal hypertension in patients with end-stage liver disease. |
| PubMedID- 24759352 | The patient was diagnosed as having chronic liver disease with portal hypertension, with etiology probably related to non-alcoholic steatohepatitis (nash), with present decompensation due to drug-induced liver injury and sbp due to s. typhimurium. |
| PubMedID- 24393789 | Mortality is closely related to liver dysfunction or portal hypertension complications due to underlying liver disease, portal thrombosis and/or massive tumour involvement[3]. |
| PubMedID- 22662598 | Clinical application of transient elastography in prediction of portal hypertension related complication in patients with chronic liver diseases. |
| PubMedID- 25646812 | On the other hand, hiv coinfection accelerates hcv-related fibrosis progression [8] and increases the risk for developing end-stage liver disease (esld) [9] with portal hypertension and hepatocellular carcinoma (hcc) [10]. |
| PubMedID- 24392231 | It occurs much more frequently in patients without underlying liver disease, but often leads to portal hypertension because the collateral veins are not able to adequately handle the splenic and mesenteric inflow. |
| PubMedID- 21196656 | Esophageal varices develop as a consequence of portal hypertension in patients with chronic liver disease and are present in approximately 50% of patients with cirrhosis of the liver. |
| PubMedID- 24803978 | portal hypertension due to chronic liver disease usually requires a longer period of time. |
| PubMedID- 23123767 | Measuring spp using ultrasound is most simple and minimally invasive, and it might be useful for evaluating portal hypertension in dogs with liver diseases. |
| PubMedID- 21229317 | Unfortunately, the patient had progressive biliary cirrhosis to end-stage liver disease complicated with portal hypertension for which she underwent successful orthotopic liver transplant at 7 years of age. |
| PubMedID- 21389796 | Noncirrhotic human nonalcoholic fatty liver disease induces portal hypertension in relation to the histological degree of steatosis. |
| PubMedID- 23343370 | Among them there was only one patient who developed severe liver disease with portal hypertension. |
| PubMedID- 20453271 | A novel mutation g-to-a at position 333 in exon v was found in two siblings having positive immunohistochemistry for aat on liver biopsy, both of whom had significant liver disease with portal hypertension. |
| PubMedID- 24340101 | Two weeks after the surgery [28], the animal model of obstructive liver disease with portal hypertension was developed. |
| PubMedID- 22689731 | Here, the authors discuss a case of pancreatic ascites developing in the setting of alcoholic liver disease with portal hypertension. |
| PubMedID- 22567478 | Significant morbidity is seen in those patients who develop complications such as end-stage renal diseases, chronic liver diseases with portal hypertension, and cancers associated with schistosomiasis [1–3]. |
Page: 1 2